India
🤝 In trade negotiations
India represents both a growing trade partner and a persistent source of friction. With average Indian tariffs of 17% — among the highest of any major economy — the US has long complained about asymmetric market access. The 26% reciprocal tariff is explicitly framed as matching India's own protectionist trade regime.
Current Tariff
📊26%
Was 3.4%
US Imports
📥$87.3B
2024 total
US Exports
📤$41.2B
2024 total
Trade Balance
⚖️$-46.1B
US deficit
Trade Flow (2024)
Tariff Rate Change
📈 5-Year Import Trend
📋 Trade Relationship Analysis
India represents both a growing trade partner and a persistent source of friction. With average Indian tariffs of 17% — among the highest of any major economy — the US has long complained about asymmetric market access. The 26% reciprocal tariff is explicitly framed as matching India's own protectionist trade regime.
Pharmaceuticals dominate the trade story: India supplies over 40% of US generic drug prescriptions and 90% of certain essential medications like metformin and azithromycin. Tariffs on Indian pharma could directly impact American healthcare costs and drug availability — a politically sensitive issue that may force exemptions.
India's response has been to negotiate rather than retaliate. Prime Minister Modi offered to lower tariffs on Harley-Davidson motorcycles, bourbon, and certain agricultural products in exchange for relief. India also positioned itself as an alternative to China for manufacturing, pointing to Apple's growing iPhone production in Chennai.
The IT services dimension is unique: Indian companies like TCS, Infosys, and Wipro employ hundreds of thousands of Americans and provide critical technology services. While services aren't directly tariffed, the broader trade tensions threaten visa policies and technology partnerships. India's massive consumer market of 1.4 billion people represents enormous potential for US exporters, giving both sides incentive to reach a deal.
Tariff Impact
Pre-2025
3.4%
Current
26%
Increase
+22.6%
🏷️ Top Imported Products
| Product | Tariff Rate | Import Value | Price Impact |
|---|---|---|---|
| Generic Pharmaceuticals | 26% | $12.8B | +15-30% on generic drug prices |
| Diamonds & Jewelry | 26% | $11.4B | +$500-2000 per carat |
| Textiles & Clothing | 26% | $9.6B | +$5-15 per garment |
| Petroleum Products | 26% | $8.2B | +8-12% refinery costs |
| Chemicals & Dyes | 26% | $7.4B | +10-15% input costs |
| IT Hardware | 26% | $5.8B | +12-18% equipment costs |
📅 Tariff Timeline
🎯 Retaliation — US Products Targeted
| US Product Targeted | US Exports at Risk | Estimated Loss |
|---|---|---|
| Almonds (California) | $840M | $500M |
| Apples (Washington) | $180M | $120M |
| Harley-Davidson Motorcycles | $60M | $40M |
| US Dairy Products | $250M | $150M |
💡 Did You Know?
- •India supplies 40% of all US generic prescriptions — tariffs could raise drug prices for millions of Americans
- •India charges 100% tariffs on US motorcycles, which became a personal grievance for Trump and sparked the trade dispute
- •Apple now manufactures iPhones in India through Foxconn — the only country besides China to do so
- •India's own average tariff of 17% is one of the highest among G20 nations